LIMK1's Role in Breast Cancer Progression
Author Information
Author(s): Brice V. McConnell, Karen Koto, Arthur Gutierrez-Hartmann
Primary Institution: University of Colorado Denver
Hypothesis
Does the localization of LIMK1 in the cytoplasm or nucleus affect its role in breast cancer progression?
Conclusion
LIMK1 activity in both the cytoplasmic and nuclear compartments promotes breast cancer progression.
Supporting Evidence
- 76% of malignant breast tissue samples strongly expressed LIMK1 in the cytoplasm.
- 52% of malignant samples also expressed nuclear LIMK1.
- Expression of GFP-LIMK1 increased MDA-MB-231 cell invasion by ~1.5-fold.
Takeaway
LIMK1 helps breast cancer grow by working in both the cell's cytoplasm and nucleus.
Methodology
Immunohistochemical analysis, Western blotting, invasion assays, and xenograft studies were performed to assess LIMK1's role in breast cancer.
Potential Biases
Potential bias in sample selection and the interpretation of immunohistochemical staining.
Limitations
The study primarily focused on one type of breast cancer cell line and may not generalize to all breast cancer types.
Participant Demographics
The study analyzed 67 normal breast tissue samples and 84 breast cancer samples.
Statistical Information
P-Value
0.0007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website